Publisher: Icon Group International, Inc.
Category: Respiratory/Pulmonary

Respiratory/Pulmonary market research reports by Icon Group International, Inc.

(57 reports matching your criteria)
    • The 2025-2030 World Outlook for Non-Small Cell Lung Cancers

      The 2025-2030 World Outlook for Non-Small Cell Lung Cancers This study covers the world outlook for non-small cell lung cancers across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in ... Read More

    • The 2025-2030 World Outlook for Imaging Used for Respiratory Disease Testing

      The 2025-2030 World Outlook for Imaging Used for Respiratory Disease Testing This study covers the world outlook for imaging used for respiratory disease testing across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.) ... Read More

    • The 2025-2030 World Outlook for Cystic Fibrosis Drugs

      The 2025-2030 World Outlook for Cystic Fibrosis Drugs This study covers the world outlook for cystic fibrosis drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of ... Read More

    • The 2025-2030 World Outlook for Cystic Fibrosis Therapeutics

      The 2025-2030 World Outlook for Cystic Fibrosis Therapeutics This study covers the world outlook for cystic fibrosis therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (i ... Read More

    • The 2025-2030 World Outlook for Pulmonary Drug Delivery Technologies

      The 2025-2030 World Outlook for Pulmonary Drug Delivery Technologies This study covers the world outlook for pulmonary drug delivery technologies across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the countr ... Read More

    • The 2025-2030 World Outlook for Pulmonary Hypertension

      The 2025-2030 World Outlook for Pulmonary Hypertension This study covers the world outlook for pulmonary hypertension across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions o ... Read More

    • The 2025-2030 World Outlook for Erdosteine

      The 2025-2030 World Outlook for Erdosteine This study covers the world outlook for erdosteine across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the per ... Read More

    • The 2025-2030 World Outlook for Pulmonary Arterial Hypertension

      The 2025-2030 World Outlook for Pulmonary Arterial Hypertension This study covers the world outlook for pulmonary arterial hypertension across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in quest ... Read More

    • The 2025-2030 World Outlook for Pulmonary Fibrosis Treatments

      The 2025-2030 World Outlook for Pulmonary Fibrosis Treatments This study covers the world outlook for pulmonary fibrosis treatments across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question ... Read More

    • The 2025-2030 World Outlook for COPD and Asthma Devices

      The 2025-2030 World Outlook for COPD and Asthma Devices This study covers the world outlook for COPD and asthma devices across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions ... Read More

    • The 2025-2030 World Outlook for Anti-Idiopathic Pulmonary Fibrosis Drugs

      The 2025-2030 World Outlook for Anti-Idiopathic Pulmonary Fibrosis Drugs This study covers the world outlook for anti-idiopathic pulmonary fibrosis drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for th ... Read More

    • The 2025-2030 World Outlook for Lung Cancer Diagnostics

      The 2025-2030 World Outlook for Lung Cancer Diagnostics This study covers the world outlook for lung cancer diagnostics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions ... Read More

    • The 2025-2030 World Outlook for Pneumonia Therapeutic Drugs

      The 2025-2030 World Outlook for Pneumonia Therapeutic Drugs This study covers the world outlook for pneumonia therapeutic drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in ... Read More

    • The 2025-2030 World Outlook for Bronchitis Treatments

      The 2025-2030 World Outlook for Bronchitis Treatments This study covers the world outlook for bronchitis treatments across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of ... Read More

    • The 2025-2030 World Outlook for Pulmonary and Respiratory Drug Deliveries

      The 2025-2030 World Outlook for Pulmonary and Respiratory Drug Deliveries This study covers the world outlook for pulmonary and respiratory drug deliveries across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for ... Read More

    • The 2025-2030 World Outlook for Alpha-1 Antitrypsin Deficiency Treatment Augmentation Therapies

      The 2025-2030 World Outlook for Alpha-1 Antitrypsin Deficiency Treatment Augmentation Therapies This study covers the world outlook for alpha-1 antitrypsin deficiency treatment augmentation therapies across more than 190 countries. For each year reported, estimates are given for the latent demand, o ... Read More

    • The 2025-2030 World Outlook for Respiratory Monitoring Devices

      The 2025-2030 World Outlook for Respiratory Monitoring Devices This study covers the world outlook for respiratory monitoring devices across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in questio ... Read More

    • The 2025-2030 World Outlook for Medical Microbiology Testing Technologies for Respiratory Diseases

      The 2025-2030 World Outlook for Medical Microbiology Testing Technologies for Respiratory Diseases This study covers the world outlook for medical microbiology testing technologies for respiratory diseases across more than 190 countries. For each year reported, estimates are given for the latent dem ... Read More

    • The 2025-2030 World Outlook for Lung Stents

      The 2025-2030 World Outlook for Lung Stents This study covers the world outlook for lung stents across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the p ... Read More

    • The 2025-2030 World Outlook for Respiratory Complications Therapeutics

      The 2025-2030 World Outlook for Respiratory Complications Therapeutics This study covers the world outlook for respiratory complications therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the co ... Read More

    • The 2025-2030 World Outlook for Lung Cancer Surgeries

      The 2025-2030 World Outlook for Lung Cancer Surgeries This study covers the world outlook for lung cancer surgeries across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of ... Read More

    • The 2025-2030 World Outlook for Respiratory Devices

      The 2025-2030 World Outlook for Respiratory Devices This study covers the world outlook for respiratory devices across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. ... Read More

    • The 2025-2030 World Outlook for Respiratory Diagnostics for Tuberculosis

      The 2025-2030 World Outlook for Respiratory Diagnostics for Tuberculosis This study covers the world outlook for respiratory diagnostics for tuberculosis across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for th ... Read More

    • The 2025-2030 World Outlook for Lung Cancer Therapeutics

      The 2025-2030 World Outlook for Lung Cancer Therapeutics This study covers the world outlook for lung cancer therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millio ... Read More

    • The 2025-2030 World Outlook for Metered-Dose Pulmonary and Respiratory Drug Delivery Systems

      The 2025-2030 World Outlook for Metered-Dose Pulmonary and Respiratory Drug Delivery Systems This study covers the world outlook for metered-dose pulmonary and respiratory drug delivery systems across more than 190 countries. For each year reported, estimates are given for the latent demand, or pote ... Read More

1 2 3

Research Assistance

Live help

Join Alert Me Now!

Sign Up

Find out more on our blog
Cookie Settings